
### [NCIT:C4345](http://purl.obolibrary.org/obo/NCIT_C4345)
**Label:** Myeloproliferative Neoplasm

**Subclasses:** [NCIT:C2862](http://purl.obolibrary.org/obo/NCIT_C2862) (Primary Myelofibrosis), [NCIT:C3179](http://purl.obolibrary.org/obo/NCIT_C3179) (Chronic Neutrophilic Leukemia), [NCIT:C7303](http://purl.obolibrary.org/obo/NCIT_C7303) (Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C27350](http://purl.obolibrary.org/obo/NCIT_C27350) (Myeloproliferative Neoplasm, Unclassifiable), [NCIT:C9129](http://purl.obolibrary.org/obo/NCIT_C9129) (Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C3336](http://purl.obolibrary.org/obo/NCIT_C3336) (Polycythemia Vera), [NCIT:C3173](http://purl.obolibrary.org/obo/NCIT_C3173) (Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9128](http://purl.obolibrary.org/obo/NCIT_C9128) (Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C7885](http://purl.obolibrary.org/obo/NCIT_C7885) (Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C4563](http://purl.obolibrary.org/obo/NCIT_C4563) (Chronic Eosinophilic Leukemia, Not Otherwise Specified), [NCIT:C9110](http://purl.obolibrary.org/obo/NCIT_C9110) (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C41238](http://purl.obolibrary.org/obo/NCIT_C41238) (Primary Myelofibrosis, Overt Fibrotic Stage), [NCIT:C3175](http://purl.obolibrary.org/obo/NCIT_C3175) (Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7320](http://purl.obolibrary.org/obo/NCIT_C7320) (Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3174](http://purl.obolibrary.org/obo/NCIT_C3174) (Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C41237](http://purl.obolibrary.org/obo/NCIT_C41237) (Primary Myelofibrosis, Prefibrotic/Early Stage), [NCIT:C41233](http://purl.obolibrary.org/obo/NCIT_C41233) (Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase), [NCIT:C41232](http://purl.obolibrary.org/obo/NCIT_C41232) (Polycythemia Vera, Polycythemic Phase), [NCIT:C9070](http://purl.obolibrary.org/obo/NCIT_C9070) (Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3407](http://purl.obolibrary.org/obo/NCIT_C3407) (Essential Thrombocythemia), 

**Class expressions from DL-Learner:**

- Thing 59.06%
- [NCIT:C36341](http://purl.obolibrary.org/obo/NCIT_C36341) (Signal Transduction Pathway Deregulation) 51.61%
- [NCIT:C38347](http://purl.obolibrary.org/obo/NCIT_C38347) (P13K-AKT Pathway Deregulation) 50.40%
- [NCIT:C38346](http://purl.obolibrary.org/obo/NCIT_C38346) (MYC Pathway Deregulation) 50.40%
- [NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation) 50.40%
- [NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation) 50.40%
- [NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation) 50.40%
- Error20 50.40%
- Error15 50.40%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) 39.28%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C36183](http://purl.obolibrary.org/obo/NCIT_C36183) (Firm Mass))) 39.28%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C36182](http://purl.obolibrary.org/obo/NCIT_C36182) (Solid Growth Pattern))) 39.28%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C36180](http://purl.obolibrary.org/obo/NCIT_C36180) (Multifocal Lesion))) 39.28%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C36177](http://purl.obolibrary.org/obo/NCIT_C36177) (Single-File Linear Pattern))) 39.28%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C36176](http://purl.obolibrary.org/obo/NCIT_C36176) (Bilateral Mass))) 39.28%


